Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
Previous studies have suggested that elderly men eliminate alprazolam more slowly than young adults. This study in the elderly was designed to determine whether a change in pharmacokinetics influences the response to alprazolam during multiple dose regimens. In addition, the study was designed to determine alprazolam pharmacokinetics and the degree to which its hydroxymetabolites accumulate, the degree of psychomotor impairment, and whether tolerance to impairment and sedation develops during three different multiple dose regimens. Twenty-six subjects completed this study. The subjects were randomized into one of three treatment groups: 0.25 mg q8h, 0.5 mg q8h, and 2 mg q12h. Subjects remained in the clinic for 8 days (day -2-day 5). Day 0 was used as a drug free testing day to establish baseline scores for sedation, digit symbol substitution (DSS), card sorting (CS) tasks, and two computer tests. Subjects received the drug according to schedule on days 1 through 4, with day 5 as the washout day. Blood samples were assayed for alprazolam, alpha-hydroxyalprazolam and 4-hydroxyalprazolam. Alpha-hydroxyalprazolam concentrations were below assay detection limits in all subjects in the 0.25 and 0.5 mg q8h groups and less than or equal to 2.6 ng/ml in the 2 mg q12h group. When detectable, 4-hydroxyalprazolam concentrations were less than 10% of the corresponding alprazolam concentration. Mean alprazolam oral clearance values in the three treatment groups ranged between 0.54 and 0.62 ml/min/kg and half-lives were in excess of 21 h. Degree of sedation and impairment was dose related. Sedation and impairment was not higher on day 4 despite concentrations 2-3 times as great as on day 1, indicating development of tolerance. Subjects were not, however, back to baseline level of performance on day 4.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The onset of tolerance to the sedative effects of BZDs usually occurs within 1-2 weeks (194,195).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [194]
In the citing paper
“Tolerance to some side effects of BZDs can also develop.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [194]
Citations
Cites
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., & Wilkinson, G. R. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107938 · Cited by 696
Use of medicines in general practice.
Skegg, D. C., Doll, R., & Perry, J. (1977) · BMJ · doi:10.1136/bmj.1.6076.1561 · Cited by 209 · cited 1×
“Kroboth As a class of drugs, benzodiazepines are prescribed extensively for elderly patients (Skegg et al. 1977).”
BackgroundEffect of age and gender on disposition of temazepam
Divoll, M., Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600701004 · Cited by 167
Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration
Smith, R. B., Kroboth, P. D., VanderLugt, J. T., Phillips, J. P., & Juhl, R. P. (1984) · Psychopharmacology · doi:10.1007/bf00431449 · Cited by 126
Self-citationAbsorption and Disposition of Chlordiazepoxide in Young and Elderly Male Volunteers
Shader, R. I., Greenblatt, D. J., Harmatz, J. S., Franke, K., & Koch‐Weser, J. (1977) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1977.tb01546.x · Cited by 106
Alprazolam Kinetics in the Elderly: Relation to Antipyrine Disposition
Greenblatt, D. J. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030057007 · Cited by 104
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics
Stoehr, G. P., Kroboth, P. D., Juhl, R. P., Wender, D. B., Phillips, J. P., & Smith, R. B. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.240 · Cited by 103
Self-citationDesmethyldiazepam kinetics in the elderly after oral prazepam
Allen, M. D., Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.150 · Cited by 81
Smith, R. B., & Kroboth, P. D. (1987) · Psychopharmacology · doi:10.1007/bf02439595 · Cited by 76 · cited 5×
“If the relationship between alprazolam effect and concentration described for young normal subjects (Smith et al. 1984; Smith and Kroboth 1987; Kroboth et al. 1988) also applies to the elderly, elderly men should experience greater effects than young men given the same doses.”
BackgroundMethodResultSelf-citation
Research works printed but not linked: 4
- Barnhill BM, Lyon JA (1984) Micrononlin for MS-DOS computers. Nonlinear regression analysis, version 1.0. Elite Software, Pittsburgh, PA
- Derry CL, Hamilton JM, Etheridge JF, Koett SL, Smith RB, Kroboth PD (1987) Effect assessment for sedative drugs: method validation and application to triazolam. Abstract Pharm Res 4(S):100
- Eberts FS, Philopoulos Y, Reineke LM, Vliek RW (1980) Disposition of14C-alprazolam, a new anxiolytic-antidepressant, in man. Abstract Pharmacologist 22:279
- SAS Institute Inc (1985) User's Guide: Statistics, Version 5th edn. SAS Institute Inc, Cary, NC
Cited by
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Clinical Pharmacokinetics of Alprazolam: Therapeutic Implications
Greenblatt, D. J., & Wright, C. E. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00003 · Cited by 352
McGaughy, J., & Sarter, M. (1995) · Psychopharmacology · doi:10.1007/bf02246109 · Cited by 346
“cokinetic differences have been reported (e.g., Kroboth et al. 1990; Greenblatt et al. 1991), the majority of the available studies concluded that the increased sensitivity of aged subjects to the cognitive effects of BZR agonists was based on age-related changes in neuronal functions.”
BackgroundPharmacodynamics in Older Adults: A Review
Bowie, M. W., & Slattum, P. W. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.10.001 · Cited by 266
Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management
Gray, S. L., Lai, K. V., & Larson, E. B. (1999) · Drug Safety · doi:10.2165/00002018-199921020-00004 · Cited by 190
Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121030-00002 · Cited by 182
Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121040-00003 · Cited by 177
Verster, J. C., & Volkerts, E. R. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00003.x · Cited by 150
Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment
Dorne, J. L. C. M., Walton, K., & RENWICK, A. G. (2003) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00209-0 · Cited by 95
Pharmacokinetic-Pharmacodynamic Relationships For Benzodiazepines
Laurijssens, B. E., & Greenblatt, D. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630010-00004 · Cited by 92
Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk.
Oo, C., Kuhn, R., Desai, N., Wright, C., & McNamara, P. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05778.x · Cited by 57
Sheikh, J. I., & Salzman, C. (1995) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30028-5 · Cited by 57
Tapiainen, V., Taipale, H., Tanskanen, A., Tiihonen, J., Hartikainen, S., & Tolppanen, A. ‐. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12909 · Cited by 53
“(18), with the exception of alprazolam that was classified as long-acting, because of its increased half-life in old adults (30).”
BackgroundBertz, R., Kroboth, P. D., Kroboth, F. J., Reynolds, I. J., Salek, F. S., Wright, C. E., & Smith, R. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36707-2 · Cited by 53
Self-citationTreatment of Anxiety Disorders in the Elderly
Sheikh, J. I., & Cassidy, E. L. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(99)00047-x · Cited by 48
Geriatric Psychopharmacology: Why Does Age Matter?
Zubenko, G. S., & Sunderland, T. (2000) · Harvard Review of Psychiatry · doi:10.3109/hrp.7.6.311 · Cited by 46
Single‐Dose Pharmacokinetics and Pharmacodynamics of Alprazolam in Elderly and Young Subjects
Kaplan, G. B., Greenblatt, D. J., Ehrenberg, B. L., Goddard, J. E., Harmatz, J. S., & Shader, R. I. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04370.x · Cited by 36
Coadministration of Nefazodone and Benzodiazepines: I. Pharmacodynamic Assessment
Kroboth, P. D., Folan, M. M., Lush, R. M., Chaikin, P. C., Shukla, U., Barbhaiya, R. H., & Salazar, D. E. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00002 · Cited by 38
Self-citationAlprazolam in End‐Stage Renal Disease: I. Pharmacokinetics
Schmith, V. D., Piraino, B., Smith, R. B., & Kroboth, P. D. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03740.x · Cited by 24
Self-citationAnxiety Disorders and their Treatment
Sheikh, J. I. (1992) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30491-9 · Cited by 22
An 87-year-old woman taking a benzodiazepine
Salzman, C. (1999) · JAMA · doi:10.1001/jama.281.12.1121 · Cited by 18
Hypnotic drugs, psychomotor performance and ageing
MORGAN, K. (1994) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1994.tb00098.x · Cited by 18
Kroboth, P. D., Folan, M. M., Bauer, K. S., Tullock, W. C., Wright, C. E., & Sweeney, J. A. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04433.x · Cited by 17
Self-citationPharmacokinetics of alprazolam in elderly patients with multiple diseases
Mühlberg, W., Rieck, W., Arnold, E., Ott, G., & Lungershausen, E. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00774-1 · Cited by 10
Influence of Endogenous Progesterone on Alprazolam Pharmacodynamics
McAuley, J. W., & Friedman, C. I. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00006 · Cited by 11
Self-citationPharmacokinetics of Alprazolam in Geriatric Patients with Neurotic Depression
Dehlin, O., Kullingsjö, H., Lidén, A., Agrell, B., Moser, G., & Olsen, I. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb02048.x · Cited by 8
Time-Dependent Sensitization to Triazolam? An Observation in Three Studies
Kroboth, P. D., McAuley, J. W., & Derry, C. L. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00007 · Cited by 7
Self-citationAlprazolam-induced panic disorder.
Bashir, A., & Swartz, C. M. (2002) · PubMed · Cited by 8
Fabian, T. J., SCHWARTZMAN, D. S., Ujhelyi, M. R., Corey, S. E., Bigos, K. L., Pollock, B. G., & Kroboth, P. D. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00416.x · Cited by 6
Self-citationDingemanse, J., Pedrazzetti, E., & van Giersbergen, P. L. M. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200103000-00003 · Cited by 3
Anxiety Disorders in the Elderly: Treatment Considerations
Iancu, I., Sasson, Y., Dannon, P. N., & Zohar, J. (1998) · KARGER eBooks · doi:10.1159/000061364 · Cited by 2
Urinary metabolic ratio of pain management and substance abuse treatment drugs: Effect of age
PESCE, A. J., Cua, A., & Wickett, E. (2026) · Journal of Opioid Management · doi:10.5055/jom.0908 · Cited by 1
The Pharmacology of Parasomnias and Movement Disorders of Sleep
Carter, G. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100472 · Cited by 1
Impact of DHEA on GABA-agonist Challenge in Healthy Young and Older adults
Folan, M. M. (2003) · D-Scholarship@Pitt (University of Pittsburgh)
Laux, G., Delini‐Stula, A., Breyer-Pfaff, U., Rickels, K., Osterheider, M., Sieberns, S., Heininger, K., Becker, T., Dietmaier, O., & Wendt, G. (1993) · Springer eBooks · doi:10.1007/978-3-7091-3317-0_5
Ojardias, É. (2020) · theses.fr (ABES) · doi:10.70675/816a44dbz52acz44a0z87ddz7694f3699601
Metadata
- Authors
- Kroboth, P. D., McAuley, J. W., & Smith, R. B.
- Affiliations
- University of Pittsburgh (US)
- Venue
- Psychopharmacology
- Published
- 1990-04
- Volume
- 100
- Issue
- 4
- Pages
- 477-484
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2000112742
- Cited by
- 35
- References
- 21
- Citations by year
- 2026: 1 · 2021: 1 · 2018: 1
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- alprazolam, older adults, pharmacokinetics, pharmacodynamics, repeated dosing, drug metabolites, sedation, psychomotor impairment, tolerance (pharmacology and immunology), oral clearance, half-life
- MeSH terms
- Aged, Aged, 80 and over, Alprazolam, Biotransformation, Drug Tolerance, Female, Half-Life, Humans, Hypnotics and Sedatives, Male, Psychomotor Performance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.